InvestorsHub Logo

Pro140

01/03/19 1:14 AM

#32671 RE: Inoviorulez #32669

Thank you for the balanced reply Inoviorulez.

So let’s only make 1 assumption that Cydy secures $480M of sales for Leronlimab by the end end of 2020 (2/31/2020) per their investor presentation.

How would you value the share price / market cap assuming 600M fully outstanding shares with warrants and options (worst case scenario).

Thanks inoviorulez.